What’s next for Pharmaceuticals in Europe?

Following the triggering of Article 50, the general election, and the first round of Brexit talks, the economic outlook for the next few years is beginning to take shape. Pharmaceuticals, one of the key common markets between the UK and the EU, will also be one of those most significantly affected, due to numerous challenges that result from the specifics of the UK-EU relationship.